Short Interest in Celcuity Inc. (NASDAQ:CELC) Decreases By 11.0%

Celcuity Inc. (NASDAQ:CELCGet Rating) saw a large decrease in short interest in the month of October. As of October 31st, there was short interest totalling 111,200 shares, a decrease of 11.0% from the October 15th total of 125,000 shares. Based on an average daily trading volume, of 40,600 shares, the days-to-cover ratio is currently 2.7 days. Approximately 1.8% of the shares of the company are short sold.

Celcuity Trading Down 1.3 %

Celcuity stock opened at $10.00 on Wednesday. The company has a current ratio of 9.74, a quick ratio of 9.74 and a debt-to-equity ratio of 0.34. The firm has a market cap of $154.60 million, a PE ratio of -4.17 and a beta of 1.00. The stock’s 50 day simple moving average is $9.66 and its two-hundred day simple moving average is $8.87. Celcuity has a 12 month low of $4.81 and a 12 month high of $18.92.

Insider Buying and Selling

In other Celcuity news, Director Richard Nigon acquired 5,000 shares of the firm’s stock in a transaction on Friday, September 9th. The stock was acquired at an average cost of $8.99 per share, for a total transaction of $44,950.00. Following the purchase, the director now owns 96,032 shares in the company, valued at approximately $863,327.68. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink. In the last quarter, insiders have sold 800 shares of company stock worth $7,686. 32.90% of the stock is owned by company insiders.

Institutional Trading of Celcuity

Hedge funds have recently added to or reduced their stakes in the company. Millennium Management LLC increased its holdings in Celcuity by 50.4% in the second quarter. Millennium Management LLC now owns 509,247 shares of the company’s stock valued at $4,634,000 after buying an additional 170,617 shares in the last quarter. Gagnon Securities LLC increased its stake in shares of Celcuity by 1.5% in the 1st quarter. Gagnon Securities LLC now owns 311,026 shares of the company’s stock valued at $2,908,000 after purchasing an additional 4,632 shares in the last quarter. State Street Corp raised its holdings in Celcuity by 3.1% in the 1st quarter. State Street Corp now owns 148,802 shares of the company’s stock worth $1,391,000 after purchasing an additional 4,466 shares during the period. PFM Health Sciences LP purchased a new position in Celcuity during the third quarter worth approximately $1,410,000. Finally, Renaissance Technologies LLC boosted its position in Celcuity by 15.3% during the second quarter. Renaissance Technologies LLC now owns 85,756 shares of the company’s stock worth $780,000 after purchasing an additional 11,400 shares in the last quarter. 56.05% of the stock is owned by hedge funds and other institutional investors.

About Celcuity

(Get Rating)

Celcuity Inc, a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment.

Featured Articles

Receive News & Ratings for Celcuity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celcuity and related companies with MarketBeat.com's FREE daily email newsletter.